Health activists and patient groups seek revision of existing Biosimilar Guideline for increased access to critical drugs
Biologics are the fastest-growing class of medications and account for a substantial and growing portion of health care costs. | Photo Credit: K.K. Mustafah Seeking immediate revision of Biosimilar Guideline (2016) to facilitate access to quality biosimilars at an affordable price, representatives of various civil societies, community and health organisations, and patient groups have written … Read more